COVID-19 Vaccine Booster Shots Will Have To Wait, FDA Tells White House: WSJ - Johnson & Johnson (NYSE:JNJ), Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)

Federal health officials have reportedly asked the White House to push back the start of a planned COVID-19 booster campaign, at least for Moderna Inc MRNA and Johnson & Johnson JNJ vaccines.
Related Content: Biden's COVID-19 Booster Plan Faces Resistance From Medical Experts.
The FDA needs more time to collect and assess the data on safety and efficacy, Wall Street Journal reports, citing people familiar with the discussions.
The White House didn't immediately respond to a request for comment on the recommended delay, which the New York Times reported earlier.
Federal health officials told the White House they might not be able to decide by September 20, clearing boosters for vaccines other than Pfizer Inc PFE - BioNTech SE's BNTX shot.
If it does start by September 20, the initial Pfizer booster campaign may need to be scaled back to include higher risk groups.
One issue stalling the discussions is whether the Moderna vaccine booster should be 50 micrograms or 100 micrograms.
Image by hakan german from Pixabay